Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children
a randomized controlled trial
Keywords:
Antipyretics, Dipyrone, Ibuprofen, Randomized controlled trial [Publication Type], FeverAbstract
CONTEXT AND OBJECTIVE: Dipyrone is a widely used over-the-counter antipyretic in Latin America, and elsewhere among Latin immigrants. Despite limited evidence, physicians often prescribe oral ibuprofen or intramuscular dipyrone as the most effective antipyretics. Our aim was to compare the antipyretic efficacy and tolerability of a single dose of oral ibuprofen, oral dipyrone or intramuscular dipyrone in febrile children. DESIGN AND SETTING: Randomized, single-blind clinical trial, at San Bartolomé Mother-Child National Teaching Hospital, Lima, Peru. METHODS: Children from six months to six years old with fever (rectal temperature: 38.3 to 39.8° C) in the emergency ward between February and June 2003 were eligible. Seventy-five children were randomly assigned to receive a single dose of oral ibuprofen (10 mg/kg), oral dipyrone (15 mg/kg) or intramuscular dipyrone (15 mg/kg). The primary outcome was mean temperature reduction after 30, 45, 60, 90 and 120 minutes. Secondary outcomes were fever-associated symptoms and clinical adverse events. RESULTS: Fever decreased by about 0.5° C after 45 minutes and by about 1.0° C after 120 minutes in all three groups. Mean tem- peratures were similar for the three groups at all times. There was a significant decrease in fever-associated symptoms for all groups. Six patients (four receiving oral dipyrone and two receiving ibuprofen) were withdrawn because of vomiting within 20 minutes after first dose of study medication. One patient assigned to oral ibuprofen presented transient urticaria. CONCLUSIONS: Antipyretic efficacy and toler- ability were similar for oral ibuprofen, oral dipyrone and intramuscular dipyrone. Oral antipyretics seem more appropriate for fever- ish children.
Downloads
References
Vauzelle-Kervroedan F, d’Athis P, Pariente-Khayat A, Debregeas S, Olive G, Pons G. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children. J Pediatr. 1997;131(5):683-7.
Purssell E. Treating fever in children: paracetamol or ibuprofen? Br J Community Nurs. 2002;7(6):316-20.
Lesko SM, Mitchell AA. The safety of acetaminophen and ibu- profen among children younger than two years old. Pediatrics. 1999;104(4):e39.
Meremikwu M, Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Database Syst Rev. 2002;(2):CD003676.
Russell FM, Shann F, Curtis N, Mulholland K. Evidence on the use of paracetamol in febrile children. Bull World Health Organ. 2003;81(5):367-72.
Wong A, Sibbald A, Ferrero F, et al. Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: results of a multinational, randomized, modified double-blind study. Clin Pediatr (Phila). 2001;40(6):313-24.
Izhar T. Novalgin in pain and fever. J Pak Med Assoc. 1999;49(9):226-7.
Cedrato AE, Passarelli I, Cimollini L, Maccarone H. Compara- ción del efecto antipirético de una dosis de dipirona, paracetamol y diclofenac resinato. Ensayo clínico multicéntrico. [Comparison of the antipyretic effect of a single dose of dipyrone, paracetamol and diclofenac resinate. A multicenter clinical trial]. Medicina (B Aires). 1989;49(6):635-6.
Lell B, Sovric M, Schmid D, et al. Effect of antipyretic drugs in children with malaria. Clin Infect Dis. 2001;32(5):838-41.
Bonkowsky JL, Frazer JK, Buchi KF, Byington CL. Metamizole use by Latino immigrants: a common and potentially harmful home remedy. Pediatrics. 2002;109(6):e98.
Meremikwu M, Oyo-Ita A. Physical methods for treating fever in children. Cochrane Database Syst Rev. 2003;(2): CD004264.
Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA. 1986;256(13):1749–57.
Edwards JE, McQuay HJ. Dipyrone and agranulocytosis: what is the risk? Lancet. 2002;360(9344):1438.
Benseñor IM. To use or not to use dipyrone? Or maybe, Cen- tral Station versus ER? That is the question. Sao Paulo Med J. 2001;119(6):190-1.
Bigal ME. To use or not to use dipyrone? Sao Paulo Med J. 2002;120(2):63.
Maluf EP. Epidemiologia da anemia aplástica no Brasil [thesis]. Faculdade de Medicina da Universidade de São Paulo; 1999.
Hamerschlak N, Maluf E, Pasquini R, et al. Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study. Sao Paulo Med J. 2005;123(3):101-4.
